Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Michael E Cloesmeijer"'
Autor:
Marjon H Cnossen, Frank W G Leebeek, Ron A A Mathôt, M Coppens, MJHA Kruip, S Polinder, K Fischer, R Liesner, K Fijnvandraat, Laura H Bukkems, PW Collins, P Chowdary, K Meijer, A Janssen, MH Cnossen, Jessica M Heijdra, Wala Al Arashi, Nico C B de Jager, Michael E Cloesmeijer, Christian M Zwaan, FWG Leebeek, RAA Mathôt, RYJ Tamminga, BAP Laros-van Gorkom, P Brons, SEM Schols, FJM van der Meer, HCJ Eikenboom, REG Schutgens, F Heubel-Moenen, L Nieuwenhuizen, P Ypma, MHE Driessens, CM Zwaan, I van Vliet, D Keeling, J Lock, HCAM Hazendonk, I van Moort, T Preijers, JM Heijdra, NCB de Jager, MCHJ Goedhart, LH Bukkems, W Al Arashi, ME Cloesmeijer
Publikováno v:
BMJ Open, Vol 12, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/1965d1889ddf4cbeb8a1d66664e6a252
Perioperative pharmacokinetic-guided factor VIII concentrate dosing in haemophilia (OPTI-CLOT trial)
Autor:
Iris van Moort, Tim Preijers, Laura H Bukkems, Hendrika C A M Hazendonk, Johanna G van der Bom, Britta A P Laros-van Gorkom, Erik A M Beckers, Laurens Nieuwenhuizen, Felix J M van der Meer, Paula Ypma, Michiel Coppens, Karin Fijnvandraat, Roger E G Schutgens, Karina Meijer, Frank W G Leebeek, Ron A A Mathôt, Marjon H Cnossen, Marjon H. Cnossen, Frank W.G. Leebeek, Ron A.A. Mathôt, Marieke J.H.A. Kruip, Suzanne Polinder, Janske Lock, Hendrika C.A.M. Hazendonk, Iris Van Moort, Jessica M. Heijdra, Marie C.H.J. Goedhart, Wala Al Arashi, Nico C.B. De Jager, Laura H. Bukkems, Michael E. Cloesmeijer, Alexander Janssen, Rienk Y.J. Tamminga, Paul Brons, Saskia E.M. Schols, Jeroen C.J. Eikenboom, Felix J.M. Van der Meer, Roger E.G. Schutgens, Kathelijne Fischer, Karin P.M. Van Galen, Erik E.A.M. Beckers, Floor C.J.I. Heubel-Moenen, Mariëtte H.E. Driessens, Ineke Van Vliet, Peter W. Collins, Ri Liesner, Pratima Chowdary, Carolyn M. Millar, Dan Hart, David Keeling
Publikováno v:
The Lancet Haematology, 8(7), e492-e502. Lancet Publishing Group
Lancet. Haematology, 8(7), e492-e502. Lancet Publishing Group
Lancet Haematology, 8, e492-e502
Lancet Haematology, 8(7), E492-E502. ELSEVIER SCI LTD
The Lancet Haematology, 8(7), E492-E502. ELSEVIER SCI LTD
Lancet Haematology, 8, 7, pp. e492-e502
Lancet. Haematology, 8(7), e492-e502. Lancet Publishing Group
Lancet Haematology, 8, e492-e502
Lancet Haematology, 8(7), E492-E502. ELSEVIER SCI LTD
The Lancet Haematology, 8(7), E492-E502. ELSEVIER SCI LTD
Lancet Haematology, 8, 7, pp. e492-e502
Contains fulltext : 237493.pdf (Publisher’s version ) (Closed access) BACKGROUND: Dosing of replacement therapy with factor VIII concentrate in patients with haemophilia A in the perioperative setting is challenging. Underdosing and overdosing of f
Autor:
Marjon H. Cnossen, Iris van Moort, Simone H. Reitsma, Moniek P.M. de Maat, Roger E.G. Schutgens, Rolf T. Urbanus, Hester F. Lingsma, Ron A.A. Mathot, Samantha C. Gouw, Karina Meijer, Annelien L. Bredenoord, Rieke van der Graaf, Karin Fijnvandraat, Alexander B. Meijer, Emile van den Akker, Ruben Bierings, Jeroen C.J. Eikenboom, Maartje van den Biggelaar, Masja de Haas, Jan Voorberg, Frank W.G. Leebeek, Ryanne A. Arisz, Minka Zivkovic, E. Shannon van Hoorn, Laura H. Bukkems, Tine M.C.H.J. Goedhart, Lorenzo G.R. Romano, Wala Al Arashi, Michael E. Cloesmeijer, Alexander Janssen, Martijn R. Brands, Lieke Baas, Jessica del Castillo Alferez, Huan Zhang, Sebastiaan N.J. Laan, Johan Boender, Johanna G. van der Bom, Mettine H.A. Bos, Lex Burdorf, Michiel Coppens, Mariette Driessens, Kathelijne F. Fischer, Lotte Haverman, Jan A. Hazelzet, Elise J. Huisman, Natalie Jansen, Sean de Jong, Marieke Kruip, Nikki van Leeuwen, Felix van der Meer, Stephan Meijer, Hans Kristian Ploos van Amstel, Suzanne Polinder, Saskia E.M. Schols, Guus Wijfjes, Kees Kluft, Waander L. van Heerde, Geertje Goedhart, Carin Uyl, Jasmijn Timp, Anke Stekelenburg, Floor Moenen, Paula Ypma, Laurens Nieuwenhuizen, Arnoud Plat
Publikováno v:
Journal of Thrombosis and Haemostasis, 20(9), 2001-2011. Wiley
Journal of Thrombosis and Haemostasis, 20(9), 2001-2011. Wiley-Blackwell
Journal of thrombosis and haemostasis, 20(9), 2001-2011. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, 20(9), 2001-2011. WILEY
Journal of Thrombosis and Haemostasis, 20(9), 2001-2011. Wiley-Blackwell Publishing Ltd
SYMPHONY consortium 2022, ' SYMPHONY consortium : Orchestrating personalized treatment for patients with bleeding disorders ', Journal of Thrombosis and Haemostasis, vol. 20, no. 9, pp. 2001-2011 . https://doi.org/10.1111/jth.15778
Journal of Thrombosis and Haemostasis, 20(9), 2001-2011. Wiley-Blackwell
Journal of thrombosis and haemostasis, 20(9), 2001-2011. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, 20(9), 2001-2011. WILEY
Journal of Thrombosis and Haemostasis, 20(9), 2001-2011. Wiley-Blackwell Publishing Ltd
SYMPHONY consortium 2022, ' SYMPHONY consortium : Orchestrating personalized treatment for patients with bleeding disorders ', Journal of Thrombosis and Haemostasis, vol. 20, no. 9, pp. 2001-2011 . https://doi.org/10.1111/jth.15778
Background: Treatment choices for individual patients with an inborn bleeding disorder are increasingly challenging due to increasing options and rising costs for society. We have initiated an integrated interdisciplinary national research program. O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f106600596b9764406a2984249fa8169
https://hdl.handle.net/1887/3494538
https://hdl.handle.net/1887/3494538
Autor:
Jessica M, Heijdra, Michael E, Cloesmeijer, Nico C B, de Jager, Frank W G, Leebeek, Marieke H J A, Kruip, Marjon H, Cnossen, Ron A A, Mathôt
Publikováno v:
Haemophilia, 28(5), 814-821. Wiley-Blackwell
Haemophilia, 28(5), 814-821. Wiley-Blackwell Publishing Ltd
Haemophilia, 28(5), 814-821. Wiley-Blackwell Publishing Ltd
Introduction: Desmopressin can be used to prevent bleeding in von Willebrand disease (VWD), but the relationship between desmopressin and von Willebrand factor activity (VWF:Act) has yet to be quantified. Aim: To quantify the relationship between des
Autor:
Marjon H Cnossen, Frank W G Leebeek, Ron A A Mathôt, M Coppens, MJHA Kruip, S Polinder, K Fischer, R Liesner, K Fijnvandraat, Laura H Bukkems, PW Collins, P Chowdary, K Meijer, A Janssen, MH Cnossen, Jessica M Heijdra, Wala Al Arashi, Nico C B de Jager, Michael E Cloesmeijer, Christian M Zwaan, FWG Leebeek, RAA Mathôt, RYJ Tamminga, BAP Laros-van Gorkom, P Brons, SEM Schols, FJM van der Meer, HCJ Eikenboom, REG Schutgens, F Heubel-Moenen, L Nieuwenhuizen, P Ypma, MHE Driessens, CM Zwaan, I van Vliet, D Keeling, J Lock, HCAM Hazendonk, I van Moort, T Preijers, JM Heijdra, NCB de Jager, MCHJ Goedhart, LH Bukkems, W Al Arashi, ME Cloesmeijer
Publikováno v:
BMJ Open, Vol 12, Iss 2 (2022)
BMJ open, 12(2):e049493. BMJ Publishing Group
BMJ Open, 12(2):e049493. BMJ Publishing Group
BMJ open, 12(2):e049493. BMJ Publishing Group
BMJ Open, 12(2):e049493. BMJ Publishing Group
IntroductionVon Willebrand disease (VWD) is a bleeding disorder, caused by a deficiency or defect of von Willebrand factor (VWF). In case of medical procedures or bleeding, patients are treated with desmopressin and/or VWF-containing concentrates to
Autor:
Michiel J van Esdonk, Anne M. Lynn, Karel Allegaert, Dick Tibboel, Klaus T. Olkkola, Youssef Daali, Anne Smits, Michael E Cloesmeijer, Paola Mian
Publikováno v:
British Journal of Clinical Pharmacology, 87(3), 1443-1454. Wiley-Blackwell Publishing Ltd
British Journal of Clinical Pharmacology (2020)
British journal of clinical pharmacology, 87(3), 1443-1454. Wiley-Blackwell
British Journal of Clinical Pharmacology (2020)
British journal of clinical pharmacology, 87(3), 1443-1454. Wiley-Blackwell
AIMS: Ketorolac is a nonsteroidal anti-inflammatory racemic drug with analgesic effects only attributed to its S-enantiomer. The aim of this study is to quantify enantiomer-specific maturational pharmacokinetics (PK) of ketorolac and investigate if t
Autor:
M. Arbouw, Fred A L van Steveninck, Michael E. Cloesmeijer, Marieke Zeeman, Polina Nassikovker, Carmen M.A. Bles, Huub L.A. van den Oever, Arriette Kruisdijk-Gerritsen, Arthur R. de Meijer, Ron A. A. Mathôt
Publikováno v:
British journal of clinical pharmacology, 86(8), 1620-1631. Wiley-Blackwell
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology
Aims The aim of this study was to investigate the population pharmacokinetics (PK) of clonidine in intensive care unit (ICU) patients in order to develop a dosing regimen for sedation. Methods We included 24 adult mechanically ventilated, sedated pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bd8ee62a47401a0dae405b1d15e9f7a
https://pure.amc.nl/en/publications/optimising-the-dose-of-clonidine-to-achieve-sedation-in-intensive-care-unit-patients-with-population-pharmacokinetics(1f130a9b-6574-43a6-8a07-c9dc9a210211).html
https://pure.amc.nl/en/publications/optimising-the-dose-of-clonidine-to-achieve-sedation-in-intensive-care-unit-patients-with-population-pharmacokinetics(1f130a9b-6574-43a6-8a07-c9dc9a210211).html